We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

917 hedge funds and large institutions have $44.1B invested in Thermo Fisher Scientific in 2014 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 329 increasing their positions, 365 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more call options, than puts

Call options by funds: $188M | Put options by funds: $114M

26% more first-time investments, than exits

New positions opened: 63 | Existing positions closed: 50

16% more funds holding in top 10

Funds holding in top 10: 5867 (+9)

2% more capital invested

Capital invested by funds: $43.2B → $44.1B (+$891M)

1% more funds holding

Funds holding: 911917 (+6)

10% less repeat investments, than reductions

Existing positions increased: 329 | Existing positions reduced: 365

1.57% less ownership

Funds ownership: 92.53%90.96% (-1.6%)

Holders
917
Holders Change
+6
Holders Change %
+0.66%
% of All Funds
26.6%
Holding in Top 10
67
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+15.52%
% of All Funds
1.94%
New
63
Increased
329
Reduced
365
Closed
50
Calls
$188M
Puts
$114M
Net Calls
+$74M
Net Calls Change
+$6.14M
Name Holding Trade Value Shares
Change
Change in
Stake
CS
576
Credential Securities
$1.39M +$15.8K +130 +1%
Daiwa Securities Group
577
Daiwa Securities Group
Japan
$1.37M -$73K -600 -5%
SKK
578
Shepherd Kaplan Krochuk
Massachusetts
$1.34M -$199K -1,637 -13%
CIC
579
Canal Insurance Company
South Carolina
$1.33M
TRCT
580
Tower Research Capital (TRC)
New York
$1.31M +$1.28M +10,528 +3,914%
BBHC
581
Brown Brothers Harriman & Co
New York
$1.29M
BBI
582
Baxter Bros Inc
Connecticut
$1.29M +$116K +956 +10%
TNBTD
583
Trustmark National Bank Trust Department
Mississippi
$1.28M -$29.2K -240 -2%
RMCM
584
Reynders McVeigh Capital Management
Massachusetts
$1.28M
Truist Financial
585
Truist Financial
North Carolina
$1.28M +$104K +857 +9%
FM
586
Family Management
New York
$1.27M +$1.27M +10,450 New
WTC
587
WhitTier Trust Company
Nevada
$1.26M -$4.26K -35 -0.3%
BIM
588
Baldwin Investment Management
Pennsylvania
$1.25M
PFM
589
PacWest Financial Management
Arizona
$1.25M +$1.25M +10,273 New
HAIM
590
Hunter Associates Investment Management
Pennsylvania
$1.25M -$30.4K -250 -2%
Envestnet Asset Management
591
Envestnet Asset Management
Illinois
$1.24M -$319K -2,624 -20%
MCWS
592
McKinley Carter Wealth Services
West Virginia
$1.23M +$1M +8,256 +438%
WF
593
Welch & Forbes
Massachusetts
$1.23M -$175K -1,440 -13%
FWIA
594
Fort Washington Investment Advisors
Ohio
$1.19M +$64.4K +530 +6%
RIM
595
Regent Investment Management
Kentucky
$1.18M +$55.9K +460 +5%
1GA
596
1st Global Advisors
Texas
$1.18M -$18.5K -152 -2%
FFC
597
First Financial Corp
Indiana
$1.17M +$5.47K +45 +0.5%
MIP
598
Marietta Investment Partners
Wisconsin
$1.16M -$23.3K -192 -2%
OA
599
OFI Advisors
Pennsylvania
$1.14M +$63.3K +521 +6%
LWM
600
LBA Wealth Management
Florida
$1.14M +$6.08K +50 +0.5%

TMO Hedge Fund Activity: Q3 2014 in Review

917 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2014, worth a combined $44.1B — up 2.1% from $43.2B a quarter earlier.

Buyers outnumbered sellers: 63 funds opened new TMO positions and 50 closed out — a net gain of 13 holders — while 329 added to existing stakes and 365 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $288M. The largest seller was Paulson & Co, exiting entirely with an estimated $381M sold.

  • 917 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2014, up from 911 in Q2 2014.
  • Funds reported $44.1B of Thermo Fisher Scientific stock for Q3 2014, up 2.1% quarter-over-quarter.
  • 63 funds opened new Thermo Fisher Scientific positions in Q3 2014 and 50 closed out, a net change of +13 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2014 was Wellington Management Group, an estimated $288M added.
  • The largest Thermo Fisher Scientific seller in Q3 2014 was Paulson & Co, an estimated $381M sold.

Based on aggregated 13F filings for Q3 2014.